The Potential for Weight Loss Drugs Keeps On Expanding

4 sources covered this compare →

Coverage diverges in the framing of the implications of these drugs. The Washington Post emphasizes the potential benefits and growing promise of these medications in addressing obesity, while Real Clear Politics also highlights the drugs'…

Editorial· May 25, 2026 · 10:16 AM UTC · 0 reactions · 0 comments · 35 views

The Potential for Weight Loss Drugs Keeps On Expanding

Pharmaceutical giant Eli Lilly announced this week that the highest dose of its new weight-loss drug helped people shed more than 30 percent of their body weight, on par with gastric bypass surgery. I

How this story was covered

4 outlets in our directory ran this story, first to last over 24 hours. Coverage spans 2 points on the political spectrum — 1 lean left, 2 lean right.

Lean left · 1Lean right · 2

▪ Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Even Covered — Forbes — Business
▪ The Promise of Weight-Loss Drugs Keeps Growing — Real Clear Politics
▪ The promise of weight-loss drugs keeps growing — Washington Post — Opinions

About this source

RealClear Markets files mainly under finance. We currently carry 447 of its stories.

All RealClear Markets coverage →

Original article

RealClear Markets · Editorial

Read full at RealClear Markets →

Story provenance

Source · retrieval · rights · ranking — open for full record

inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisher	RealClear Markets
Canonical URL	https://www.realclearmarkets.com/2026/05/25/the_potential_for_weight_loss_drugs_keeps_on_expanding_1184524.html
Publication time	Mon, 25 May 2026 05:16:08 -0500
Retrieval time	2026-05-25T10:22:36.994Z
Last seen	2026-05-25T10:22:36.994Z
Headline source	Publisher (no WeSearch rewrite)
Excerpt source	publisher description
Excerpt method	Publisher-supplied description / RSS summary field.
Summary	None yet
Summary source text	description
Citation coverage	No WeSearch summary has been generated for this story yet.
Cluster	Nkn40WmPfF87 · 4 stories
Cluster logic	Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reason	Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visit	Yes — open original
Substitutes article?	No — link-out required for full text

Rights status (four layers)

Publisher-declared

No publisher-confirmed rights record for this source yet.

Machine-readable

No source-specific machine-readable restriction detected beyond the public feed.

WeSearch interpretation

WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.

Unknown

Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing	May the item be indexed (stored, ranked, made findable)?	Allowed
Snippet	May a short excerpt of the publisher's text be shown?	Allowed
AI summary	May WeSearch generate its own short summary of the article?	Limited
Retrieval / RAG	May the content be exposed for third-party retrieval-augmented generation?	Not asserted
Model training	May the content be used to train AI models?	Not asserted
Commercial reuse	May the content be reused commercially?	Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Open original publisher → Source rights JSON → Machine-readable provenance → Rights framework → WESEARCH-STORY-PROVENANCE-V1

Anonymous · no account needed

Discussion

0 comments